About
Oticon Medical is a subsidiary of the Demant Group, dedicated to developing advanced hearing implant solutions. Established in 2007, the company focuses on hearing implants rather than traditional hearing aids. Its headquarters is located in Denmark, with research and development facilities in Gothenburg, Sweden, and a cochlear implant division near Nice, France. The U.S. subsidiary is based in Somerset, New Jersey. The company specializes in bone-anchored hearing systems (BAHS) and cochlear implants. The Ponto bone conduction implant, now in its fifth generation, is designed for individuals with conductive hearing loss, mixed hearing loss, or single-sided deafness. Following the acquisition of Neurelec in 2013, Oticon Medical expanded its offerings to include cochlear implants for those with severe to profound sensorineural hearing loss. Their products aim to restore hearing by bypassing damaged parts of the ear and directly stimulating the auditory system, providing alternatives for patients who do not benefit from conventional hearing aids.
Technologies
Keywords
Company Information
-
Employees 480
-
Founded 2009
-
Annual Revenue $1000000000
Location
9 Kongebakken, Smorum, Denmark, 2765